Personnes dépendantes : thématiques

Tout le contenu de la veille

Lannoy, S., Fama, R., Sassoon, S. A., Le Berre, A.-P., Asok, P., Zahr, N. M., Pfefferbaum, A., & Sullivan, E. V. (2022). A prospective study revealing a compounded burden of COVID-19, sex, and clinical diagnosis of alcohol use disorder and HIV infection on quality of life, anxiety, and alcohol use. Journal of Psychiatric Research, 152, 152–159.
Spillane, N. S., Schick, M. R., Nalven, T., Crawford, M. C., & Martz, A. S. (2022). A Retrospective Examination of Changes in Drinking Motives During the Early COVID-19 Pandemic. The International Journal of Psychiatry in Medicine, Prépublication, 009121742211100.
Heradstveit, O., Sivertsen, B., Lønning, K.-J., & Skogen, J. C. (2022). The Extent of Alcohol-Related Problems Among College and University Students in Norway Prior to and During the COVID-19 Pandemic. Frontiers in Public Health, 10, 876841.
Durand, L., Keenan, E., Boland, F., Harnedy, N., Delargy, Í., Scully, M., Mayock, P., Ebbitt, W., Vázquez, M. O., Corrigan, N., Killeen, N., Pate, M., Byrne, P., & Cousins, G. (2022). Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the COVID-19 pandemic: a national Delphi study. International Journal of Drug Policy, Prépublication, 103768.
Pallavicini, F., Pepe, A., & Mantovani, F. (2022). The Effects of Playing Video Games on Stress, Anxiety, Depression, Loneliness, and Gaming Disorder During the Early Stages of the COVID-19 Pandemic: PRISMA Systematic Review. Cyberpsychology, Behavior, and Social Networking, 25(6), 334–354.
Maeng, D., Li, Y., Lawrence, M., Keane, S., Cross, W., Conner, K. R., & Lee, H. B. (2022). Impact of mandatory COVID‐19 shelter‐in‐place order on controlled substance use among rural versus urban communities in the United States. The Journal of Rural Health, Prépublication, jrh.12688.
Wakabayashi, M., Takada, M., Kinjo, A., Sugiyama, Y., Iso, H., & Tabuchi, T. (2022). Problem drinkers and high risk-taking behaviors under the stay-at-home policy of the COVID-19 emergency declaration. BMC Public Health, 22(1), 1173.
Muhammad, J. S., Siddiqui, R., & Khan, N. A. (2022). COVID-19 and alcohol use disorder: putative differential gene expression patterns that might be associated with neurological complications. Hospital Practice, Prépublication, 21548331.2022.2088183.
Walby, F. A., Myhre, M. Ø., & Mehlum, L. (2022). Suicide among users of mental health and addiction services in the first 10 months of the COVID-19 pandemic: observational study using national registry data. BJPsych Open, 8(4), e111.
Glegg, S., McCrae, K., Kolla, G., Touesnard, N., Turnbull, J., Brothers, T. D., Brar, R., Sutherland, C., Le Foll, B., Sereda, A., Goyer, M.-È., Rai, N., Bernstein, S., & Fairbairn, N. (2022). “COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada. International Journal of Drug Policy, 106, 103742.
Al-Imam, A., Motyka, M. A., Witulska, Z., Younus, M., & Michalak, M. (2022). Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland. International Journal of Environmental Research and Public Health, 19(11), 6619.
Jalodia, R., Antoine, D., Braniff, R. G., Dutta, R. K., Ramakrishnan, S., & Roy, S. (2022). Opioid-Use, COVID-19 Infection, and Their Neurological Implications. Frontiers in Neurology, 13, 884216.
Sheikhan, N. Y., Hawke, L. D., Ma, C., Courtney, D., Szatmari, P., Cleverley, K., Voineskos, A., Cheung, A., & Henderson, J. (2022). A Longitudinal Cohort Study of Youth Mental Health and Substance use Before and During the COVID-19 Pandemic in Ontario, Canada: An Exploratory Analysis. The Canadian Journal of Psychiatry, Prépublication, 07067437221097906.
Federico, A., Mazzarella, C., Spina, A., Dallio, M., Romeo, M., Masarone, M., Persico, M., Gravina, A. G., Luzza, F., Abenavoli, L., Mauro, M. D., & Loguercio, C. (2022). Alcoholic consumption of young Italians during the SARS-CoV-2 pandemic. Reviews on Recent Clinical Trials, 17.
Vallecillo, G., Durán, X., Canosa, I., Roquer, A., Martinez, M. C., & Perelló, R. (2022). COVID-19 vaccination coverage and vaccine hesitancy among people with opioid use disorder in Barcelona, Spain. Drug and Alcohol Review, Prépublication.
Owiti, J. A., Benson, M., Maplanka, M., Oluseye, L., & Carvalho, D. (2022). Is Methadone Safe for Patients With Opioid Use Disorder and Coronavirus Disease 2019 Infection? Journal of Addictions Nursing, 33(2), 86–94.
Guillot, C. R., Moore, E. W. G., & Petrie, T. A. (2022). Drinking among college student athletes during the COVID-19 pandemic. Journal of American College Health, Prépublication, 1–5.
Iversen, J., Wand, H., Kemp, R., Bevan, J., Briggs, M., Patten, K., Heard, S., & Maher, L. (2022). Uptake of COVID-19 vaccination among people who inject drugs. Harm Reduction Journal, 19(1), 59.
Banks, D. E., Paschke, M. E., Li, X., Fentem, A., Rich, A., Szlyk, H. S., & Cavazos-Rehg, P. (2022). Opioid Use Disorder and COVID-19: Treatment and Recovery Factors among Vulnerable Populations at the Intersection of Two U.S. Epidemics. Journal of Psychoactive Drugs, 0(0), 1–9.
Chaiton, M., Billington, R., Copeland, I., Grey, L., & Abramovich, A. (2022). Mental Health and Addiction Services Exclusive to LGBTQ2S+ during COVID-19: An Environmental Scan. International Journal of Environmental Research and Public Health, 19(10), 5919.
May, T., Dawes, J., Fancourt, D., & Burton, A. (2022). A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives. International Journal of Drug Policy, 106, 103752.
Feinberg, M. E., Fang, S., Fosco, G. M., Sloan, C. J., Mogle, J., & Spoth, R. L. (2022). Long-term Effects of Adolescent Substance Use Prevention on Participants, Partners, and their Children: Resiliency and Outcomes 15 Years Later During the COVID-19 Pandemic. Prevention Science, Prépublication.
Moshkforoush, M., DeBeck, K., Brar, R., Fairbairn, N., Cui, Z., Milloy, M.-J., Buxton, J., Oldenburger, T., McLellan, W., Kendall, P., Sedgemore, K., Wilson, D., Kerr, T., & Hayashi, K. (2022). Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada. Harm Reduction Journal, 19(1), 50.
Brailovskaia, J., & Margraf, J. (2022). Addictive social media use during Covid-19 outbreak: Validation of the Bergen Social Media Addiction Scale (BSMAS) and investigation of protective factors in nine countries. Current Psychology, Prépublication.
Lei, F., Lofwall, M. R., Freeman, P. R., Slade, E., Vickers-Smith, R., & Slavova, S. (2022). Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky. The Journal of Rural Health, Prépublication.
Lui, B., White, R. S., Aaronson, J., & Hoyler, M. (2022). Economic burden of drug overdose deaths before and during the COVID-19 pandemic in the USA. Journal of Comparative Effectiveness Research, 11(9), 643–648.
Avalone, L., King, C., Popeo, D., Perkel, C., Abara, C. J., Linn-Walton, R., Gasca, V., Vitagliano, L., Barron, C., & Fattal, O. (2022). Increased Attendance During Rapid Implementation of Telehealth for Substance Use Disorders During COVID-19 at the Largest Public Hospital System in the United States. Substance Use & Misuse, Prépublication, 1–6.
Hamilton, H. R., Armeli, S., & Tennen, H. (2022). Coping with COVID: COVID-19 experiences and drinking to cope. Journal of Substance Use, Prépublication.
Joyce, K. M., Cameron, E. E., Sulymka, J., Protudjer, J. L. P., & Roos, L. E. (2022). Changes in Maternal Substance Use During the COVID-19 Pandemic. Journal of Studies on Alcohol and Drugs, 83(3), 352–357.
Hoffman, K. A., Foot, C., Levander, X. A., Cook, R., Terashima, J. P., McIlveen, J. W., Korthuis, P. T., & McCarty, D. (2022). Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis. Journal of Substance Abuse Treatment, Prépublication, 108801.
Alinsky, R. H., Prichett, L., Chang, H.-Y., Alexander, G. C., Stein, B. D., & Saloner, B. (2022). Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic. Journal of Adolescent Health.
Zhang, Y., Hou, Z., Wu, S., Li, X., Hao, M., & Wu, X. (2022). The relationship between internet addiction and aggressive behavior among adolescents during the COVID-19 pandemic: Anxiety as a mediator. Acta Psychologica, 227, 103612.
Glick, J. L., Grieb, S. M., Harris, S. J., Weir, B. W., Smith, K. C., Puryear, T., Hamilton White, R., & Allen, S. T. (2022). Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky. Harm Reduction Journal, 19(1), 47.
Acharya, B., & Dhakal, C. (2022). Risky health behaviors during the COVID-19 pandemic: Evidence from the expenditures on alcohol, non-alcoholic beverages, and tobacco products. PLOS ONE, 17(5), e0268068.
Ambrosini, F., Truzoli, R., Vismara, M., Vitella, D., & Biolcati, R. (2022). The effect of cyberchondria on anxiety, depression and quality of life during COVID-19: the mediational role of obsessive-compulsive symptoms and Internet addiction. Heliyon, 8(5), e09437.
Parks, M. J., Fleischer, N. L., & Patrick, M. E. (2022). Increased nicotine vaping due to the COVID-19 pandemic among US young adults: Associations with nicotine dependence, vaping frequency, and reasons for use. Preventive Medicine, 159, 107059.
Meadowcroft, D., & Davis, W. (2022). Understanding the Effect of the COVID-19 Pandemic on Substance Use Disorder Treatment Facility Operations and Patient Success: Evidence From Mississippi. Substance Abuse: Research and Treatment, 16, 11782218221095872.
Napoletano, S., Basile, G., Faro, A. F. L., & Negro, F. (2022). New Psychoactive Substances and receding COVID-19 pandemic: really going back to “normal”? Acta Biomedica Atenei Parmensis, 93(2), e2022186–e2022186.
Zysset, A., Volken, T., Amendola, S., von Wyl, A., & Dratva, J. (2022). Change in Alcohol Consumption and Binge Drinking in University Students During the Early COVID-19 Pandemic. Frontiers in Public Health, 10.
Cunningham, J. K., Scott, D. P., Molina, F. F., & Solomon, T. G. A. (2022). Services and Challenges at a Native American Residential Substance Use Disorder Treatment Center during the COVID-19 Pandemic. Journal of Health Care for the Poor and Underserved, 33(2), 1107–1113.
Chen, C., & Shen, S. (2022). Trend analysis of drug overdose deaths before and during the COVID-19 pandemic. American Journal of Translational Research, 14(4), 2685–2688.
Koeger, M., Schillok, H., Voss, S., Coenen, M., Merkel, C., Jung-Sievers, C., & On behalf of the COSMO Study Team. (2022). Alcohol Use of German Adults during Different Pandemic Phases: Repeated Cross-Sectional Analyses in the COVID-19 Snapshot Monitoring Study (COSMO). International Journal of Environmental Research and Public Health, 19(9), 5489.
Batterham, P. J., Shou, Y., Farrer, L. M., Murray, K., Morse, A. R., Gulliver, A., Slade, T., Newton, N. C., & Calear, A. L. (n.d.). Patterns and predictors of alcohol use during the early stages of the COVID-19 pandemic in Australia: Longitudinal cohort study. Alcoholism: Clinical and Experimental Research, n/a(n/a).
Williams, L. D., Lee, E., Latkin, C., Mackesy-Amiti, M. E., Kaufmann, M., Copulsky, E., Kaplan, C., & Boodram, B. (2022). Economic Challenges and Behavioral and Mental Health Risks for Overdose during the COVID-19 Pandemic among People Who Inject Drugs. International Journal of Environmental Research and Public Health, 19(9), 5351.
Whiteman, S. D., Maiya, S., Cassinat, J. R., Serang, S., Kelly, B. C., Mustillo, S. A., & Maggs, J. L. (2022). Sibling influences on adolescent alcohol use during the spring 2020 COVID-19 pandemic shutdown. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, Prépublication.
Markoulakis, R., Da Silva, A., Kodeeswaran, S., & Levitt, A. (2022). Youth mental health and/or addiction concerns and service needs during the COVID-19 pandemic: a qualitative exploration of caregiver experiences and perspectives. Child and Adolescent Psychiatry and Mental Health, 16(1), 35.
Bloomfield, K., Kilian, C., Manthey, J., Rehm, J., Brummer, J., & Grittner, U. (2022). Changes in Alcohol Use in Denmark during the Initial Months of the COVID-19 Pandemic: Further Evidence of Polarization of Drinking Responses. European Addiction Research, 1–12.
Centre canadien sur les dépendances et l’usage de substances, & Commission de la santé mentale du Canada. (2022). Santé mentale et usage de substances pendant la pandémie de COVID-19 : rapport sommaire 5 : les idées suicidaires et l’usage de substances. CCDUS, CSMC.
Hoffman, K. A., Foot, C., Levander, X. A., Cook, R., Terashima, J. P., McIlveen, J. W., Korthuis, P. T., & McCarty, D. (2022). Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis. Journal of Substance Abuse Treatment, Prépublication, 108801.
Estévez-Danta, A., Bijlsma, L., Capela, R., Cela, R., Celma, A., Hernández, F., Lertxundi, U., Matias, J., Montes, R., Orive, G., Prieto, A., Santos, M. M., Rodil, R., & Quintana, J. B. (2022). Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology. Science of The Total Environment, Prépublication, 155697.